| Advanced Pain Center | |
|
1234 South Garfield Ave. Suite 205 Alhamabra CA 91801 | |
| (626) 457-6700 | |
| (626) 457-6750 |
| Full Name | Advanced Pain Center |
|---|---|
| Speciality | Specialist |
| Location | 1234 South Garfield Ave., Alhamabra, California |
| Authorized Official Name and Position | Chong-hao Zhao (PRESIDENT/ MEDICAL DIRECTOR) |
| Authorized Official Contact | 8188421688 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Advanced Pain Center 1234 South Garfield Ave. Suite 205 Alhamabra CA 91801 Ph: (626) 457-6700 | Advanced Pain Center 1234 South Garfield Ave. Suite 205 Alhamabra CA 91801 Ph: (626) 457-6700 |
| NPI Number | 1356405591 |
|---|---|
| Provider Enumeration Date | 12/21/2006 |
| Last Update Date | 03/03/2011 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356405591 | NPI | - | NPPES |
| A71882 | Other | CA | PIN |
News Archive
Cryo-Cell International, Inc., one of the world's largest and most established family cord blood banks and global stem cell innovators, today announced at the annual meeting of the American Society of Reproductive Medicine (ASRM) that the Company has formalized an industry-exclusive agreement with MedTech For Solutions, Inc., a Group Purchasing Organization (GPO) representing a member network of 115 practices specializing in reproductive medicine, which operates in conjunction with The Broadlane Group.
"The massacre in Syria rages on and yet we stand idle. We must realize that, to millions of Syrians trapped in the country, the virtual absence of humanitarian relief is nearly as arbitrary and cruel as the war itself," Desmond Tutu, archbishop emeritus of Cape Town and a Nobel peace laureate, writes in The Guardian's "Comment is Free" blog.
With modern advances in genetic engineering occurring almost every day, the latest discovery concerns antibiotic resistance. Using the powerful gene editor CRISPR, scientists reported the development of a gene-drive system that is 100 times as efficient as other current systems at inactivating a specific bacterial gene responsible for making the bacterium antibiotic-resistant and which is present as multiple copies within the same bacterial cell.
OncoSec Medical Incorporated, a developer of innovative medical approaches to treat solid tumor cancers with unmet medical needs, announced today that on March 24, 2011 it completed its acquisition of certain assets of Inovio Pharmaceuticals, Inc. and entered into a license agreement with Inovio, pursuant to the terms of an asset purchase agreement with Inovio entered into on March 14, 2011.
› Verified 7 days ago